Morrison Gregory 4
4 · Wright Medical Group N.V. · Filed Nov 14, 2017
Insider Transaction Report
Form 4
Morrison Gregory
Global VP, Human Resources
Transactions
- Sale
Ordinary Shares, par value EUR 0.03 per share
2017-11-10$23.74/sh−50,140$1,190,419→ 77,488 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-10$20.62/sh−39,241$809,149→ 39,307 totalExercise: $20.62Exp: 2025-10-13→ Ordinary Shares (39,241 underlying) - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2017-11-10$21.24/sh+10,899$231,495→ 88,387 total - Exercise/Conversion
Ordinary Shares, par value EUR 0.03 per share
2017-11-10$20.62/sh+39,241$809,149→ 127,628 total - Sale
Ordinary Shares, par value EUR 0.03 per share
2017-11-13$23.65/sh−42,000$993,103→ 35,488 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-10$21.24/sh−10,899$231,495→ 23,991 totalExercise: $21.24Exp: 2026-07-19→ Ordinary Shares (10,899 underlying)
Footnotes (5)
- [F1]Includes 22,680 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 5,989 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.62 to $24.02, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.51 to $23.82, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]This option vested with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
- [F5]This option vested with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.